Trypanosoma cruzi: chemotherapeutic effects of clomipramine in mice infected with an isolate obtained from an endemic area.

The susceptibility of Trypanosoma cruzi strains to nifurtimox and benznidazole has been investigated and resistant strains have been described. Some tricyclic drugs are lethal for trypomastigote and epimastigote forms of T. cruzi (Tulahuen strain) and prevent the disease in mice. We investigated whether clomipramine, a tricyclic antidepressant drug with anti-trypanothione reductase and anti-calmodulin effects, could be effective in treating Albino Swiss mice infected with trypomastigotes of a new T. cruzi isolate from a chronic patient from an endemic area of Argentina in two different treatment schedules. Both treatment schedules were effective in reducing electrocardiographic changes and preventing myocardial structural damage. The cardiac beta-receptors low affinity was compensated for by an increment in their density. This probably maintained cardiac function since 70% of the mice survived for more than 2 years even though anti-cruzipain titers remained high. These results demonstrate that clomipramine, clinically used as a neuroleptic, could be a promising trypanocidal agent for the treatment of Chagas' disease.
AuthorsH W Rivarola, J M Bustamante, S Lo Presti, A R Fernández, J E Enders, S Gea, R Fretes, P Paglini-Oliva
JournalExperimental parasitology (Exp Parasitol) Vol. 111 Issue 2 Pg. 80-6 (Oct 2005) ISSN: 0014-4894 [Print] United States
PMID16085036 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Protozoan
  • Antidepressive Agents, Tricyclic
  • Antigens, Protozoan
  • Calmodulin
  • Immunoglobulin G
  • Receptors, Adrenergic, beta
  • Trypanocidal Agents
  • Cysteine Endopeptidases
  • cruzipain
  • Clomipramine
  • Animals
  • Antibodies, Protozoan (blood)
  • Antidepressive Agents, Tricyclic (pharmacology, therapeutic use)
  • Antigens, Protozoan (immunology)
  • Calmodulin (antagonists & inhibitors)
  • Chagas Cardiomyopathy (parasitology, prevention & control)
  • Chagas Disease (drug therapy, parasitology, pathology)
  • Clomipramine (pharmacology, therapeutic use)
  • Cysteine Endopeptidases (immunology)
  • Drug Resistance
  • Electrocardiography
  • Humans
  • Immunoglobulin G (blood)
  • Male
  • Mice
  • Myocardium (metabolism, pathology)
  • Parasitemia (drug therapy, parasitology)
  • Receptors, Adrenergic, beta (drug effects, metabolism)
  • Trypanocidal Agents (adverse effects, pharmacology, therapeutic use)
  • Trypanosoma cruzi (drug effects, immunology, pathogenicity)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: